Drug Search Results
More Filters [+]

Laniquidar

Alternative Names: laniquidar
Latest Update: 2012-07-18
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Imaging Agent Imaging Agent

Novel Mechanism: Yes

Modality: Diagnostic Agent

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: EORTC
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Laniquidar

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Breast Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

EORTC-10003-16004

P2

Completed

Breast Cancer

2002-06-01

Recent News Events

Date

Type

Title